Gross G J, Warltier D C, Hardman H F
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee 53226.
J Cardiovasc Pharmacol. 1987 Nov;10(5):535-42. doi: 10.1097/00005344-198711000-00007.
The effects of the nicotinamide nitrate compound nicorandil (SG-75) and the slow channel calcium entry blocker nifedipine on the recovery of subendocardial segment shortening (% SS) were compared with a vehicle-treated group following 30 min of left anterior descending coronary artery (LAD) occlusion and 3 h of reperfusion. Sonomicrometry was used to determine % SS in ischemic and nonischemic myocardium, and radioactive microspheres were used to determine regional myocardial blood flow. Nicorandil (100-micrograms/kg bolus followed by 25 micrograms/kg/min i.v.), nifedipine (10-micrograms/kg bolus followed by 3 micrograms/kg/min i.v.), or vehicle (saline) was administered 15 min prior to and throughout the occlusion period. Both drugs produced equivalent decreases in the heart rate X systolic pressure product before and during LAD occlusion. In addition, total left ventricular weights, the area at risk, the percent of the left ventricle at risk, and collateral blood flow were similar in all three groups. During coronary occlusion, % SS in the ischemic region was equally depressed in each series and passive systolic lengthening resulted. However, following reperfusion, only the nicorandil-treated animals showed an improvement in myocardial segment function through 3 h of reperfusion as compared with the control group. Transmural myocardial blood flow within the ischemic region during reperfusion returned to control values in all three groups; however, the endocardial/epicardial blood flow ratio (endo/epi) was significantly decreased in the control and nicorandil-treated dogs. In contrast, the endo/epi was greater than the preocclusion control in the nifedipine series during reperfusion. Thus, although the mechanism of action of nicorandil in this model is unknown, the improvement in % SS in the nicorandil-treated group was not related to changes in peripheral hemodynamics or improved regional blood flow, since nifedipine produced similar changes in hemodynamics and resulted in a better recovery of perfusion.
在左前降支冠状动脉(LAD)闭塞30分钟并再灌注3小时后,将硝酸烟酰胺化合物尼可地尔(SG - 75)和慢通道钙内流阻滞剂硝苯地平对心内膜下节段缩短恢复率(%SS)的影响与溶剂处理组进行了比较。采用超声心动图测量法确定缺血和非缺血心肌中的%SS,并使用放射性微球确定局部心肌血流量。在闭塞前15分钟及整个闭塞期间给予尼可地尔(静脉推注100微克/千克,随后以25微克/千克/分钟静脉滴注)、硝苯地平(静脉推注10微克/千克,随后以3微克/千克/分钟静脉滴注)或溶剂(生理盐水)。在LAD闭塞前和闭塞期间,两种药物均使心率×收缩压乘积同等程度降低。此外,三组的左心室总重量、危险面积、左心室危险百分比和侧支血流量相似。在冠状动脉闭塞期间,每个系列中缺血区域的%SS均同等程度降低,并出现被动收缩期延长。然而,再灌注后,与对照组相比,仅尼可地尔治疗的动物在3小时再灌注期间心肌节段功能有所改善。再灌注期间缺血区域的透壁心肌血流量在所有三组中均恢复至对照值;然而,对照组和尼可地尔治疗的犬的心内膜/心外膜血流量比值(endo/epi)显著降低。相比之下,硝苯地平组在再灌注期间endo/epi大于闭塞前对照值。因此,尽管在该模型中尼可地尔的作用机制尚不清楚,但尼可地尔治疗组中%SS的改善与外周血流动力学变化或局部血流改善无关,因为硝苯地平产生了相似的血流动力学变化并导致更好的灌注恢复。